REBETOL (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the REBETOL drug offered from Merck Sharp & Dohme Corp.. This Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
NON-PROPRIETARY NAME: | ribavirin |
SUBSTANCE NAME: | RIBAVIRIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1998-06-03 |
END MARKETING DATE: | 0000-00-00 |
REBETOL HUMAN PRESCRIPTION DRUG Details:
Item Description | REBETOL from Merck Sharp & Dohme Corp. |
LABELER NAME: | Merck Sharp & Dohme Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/1) |
START MARKETING DATE: | 1998-06-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0085-1194_a9e99485-26c9-4768-abee-f6629dd7092b |
PRODUCT NDC: | 0085-1194 |
APPLICATION NUMBER: | NDA020903 |
Other RIBAVIRIN Pharmaceutical Manufacturers / Labelers: